Essential Oil Monoterpenes
What is it? Overview Usage Side Effects and Warnings
Answers
askAsk

Essential Oil Monoterpenes Usage

Written by FoundHealth.

Usages

Effect of Essential Oil Monoterpenes on Viral Upper Respiratory Infections (Colds and Influenza)

Essential oil monoterpenes are thought to help by thinning mucus.

Read more about Viral Upper Respiratory Infections (Colds and Influenza) and Essential Oil Monoterpenes.

Therapeutic Uses of Essential Oil Monoterpenes

Most, though not all, studies indicate that oral use of essential oil monoterpenes can help acute bronchitis, chronic bronchitis, and sinus infections. 1 2 3 4 5 For example, a double-blind , placebo-controlled trial of 676 people with acute bronchitis found that 2 weeks treatment with essential oil monoterpenes was more effective than placebo and equally effective as antibiotic treatment for reducing symptoms and aiding recovery. 6 Also, a 3-month, double-blind , placebo-controlled trial of 246 people with chronic bronchitis found that regular use of essential oil monoterpenes helped prevent the typical worsening of chronic bronchitis that occurs during the winter. 7 Additionally, in a double-blind, placebo-controlled study of about 300 people, use of essential oil monoterpenes improved symptoms of acute sinusitis . 8 One study weakly indicates that essential oil monoterpenes may be helpful for colds in children. 9 Essential oil monoterpenes are thought to work by thinning mucus.

References

  1. Federspil P, Wulkow R, Zimmermann T. [Effects of standardized Myrtol in therapy of acute sinusitis--results of a double-blind, randomized multicenter study compared with placebo] Laryngorhinootologie. 76(1):23-7.
  2. Behrbohm H, Kaschke O, Sydow K. [Effect of the phytogenic secretolytic drug Gelomyrtol forte on mucociliary clearance of the maxillary sinus] Laryngorhinootologie. 74(12):733-7.
  3. Meister R, Wittig T, Beuscher N, et al. Efficacy and tolerability of Myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators. Arzneimittelforschung. 1999;49:351–358.
  4. Matthys H, de Mey C, Carls C, Ryś A, Geib A, Wittig T. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneimittelforschung. 50(8):700-11.
  5. Ulmer WT, Schött D. [Chronic obstructive bronchitis. Effect of Gelomyrtol forte in a placebo-controlled double-blind study] Fortschr Med. 109(27):547-50.
  6. Matthys H, de Mey C, Carls C, Ryś A, Geib A, Wittig T. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneimittelforschung. 50(8):700-11.
  7. Meister R, Wittig T, Beuscher N, et al. Efficacy and tolerability of Myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators. Arzneimittelforschung. 1999;49:351–358.
  8. Federspil P, Wulkow R, Zimmermann T. [Effects of standardized Myrtol in therapy of acute sinusitis--results of a double-blind, randomized multicenter study compared with placebo] Laryngorhinootologie. 76(1):23-7.
  9. Sengespeik HC, Zimmermann T, Peiske C, de Mey C. [Myrtol standardized in the treatment of acute and chronic respiratory infections in children. A multicenter post-marketing surveillance study] Arzneimittelforschung. 48(10):990-4.
 
Share

0 Comments

No one has made any comments yet. Be the first!

Your Comment